Correlating with clinical features, the expression levels of ITGAM are positively associated with the severity of the stroke, poorer functional outcome, and the extent of infarction, drawing our attention to the potential of has-miR-3646-ITGAM as a therapeutic target for IS. This evidence concerns the gene ITGAM and stroke disorder.